Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

293 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prevalence and clinical features of cervical dystonia in Parkinson's disease.
Higginbotham L, Scorr LM, Parra SP, Sommerfeld B, Jinnah HA, Factor SA. Higginbotham L, et al. Among authors: factor sa. Parkinsonism Relat Disord. 2024 Oct;127:107114. doi: 10.1016/j.parkreldis.2024.107114. Epub 2024 Aug 23. Parkinsonism Relat Disord. 2024. PMID: 39197296
LRRK2 levels in immune cells are increased in Parkinson's disease.
Cook DA, Kannarkat GT, Cintron AF, Butkovich LM, Fraser KB, Chang J, Grigoryan N, Factor SA, West AB, Boss JM, Tansey MG. Cook DA, et al. Among authors: factor sa. NPJ Parkinsons Dis. 2017 Mar 28;3:11. doi: 10.1038/s41531-017-0010-8. eCollection 2017. NPJ Parkinsons Dis. 2017. PMID: 28649611 Free PMC article.
Parkinson's Disease: Motor Fluctuations.
Factor SA. Factor SA. Curr Treat Options Neurol. 1999 Mar;1(1):21-32. doi: 10.1007/s11940-999-0029-1. Curr Treat Options Neurol. 1999. PMID: 11096692
Common Genetic Variant Association with Altered HLA Expression, Synergy with Pyrethroid Exposure, and Risk for Parkinson's Disease: An Observational and Case-Control Study.
Kannarkat GT, Cook DA, Lee JK, Chang J, Chung J, Sandy E, Paul KC, Ritz B, Bronstein J, Factor SA, Boss JM, Tansey MG. Kannarkat GT, et al. Among authors: factor sa. NPJ Parkinsons Dis. 2015;1:15002-. doi: 10.1038/npjparkd.2015.2. Epub 2015 Apr 22. NPJ Parkinsons Dis. 2015. PMID: 27148593 Free PMC article.
Deutetrabenazine Provides Long-Term Benefit for Tardive Dyskinesia Regardless of Underlying Condition and Dopamine Receptor Antagonist Use: A Post Hoc Analysis of the 3-Year, Open-Label Extension Study.
Hauser RA, Barkay H, Fernandez HH, Jimenez-Shahed J, Factor SA, Gross N, Marinelli L, Gordon MF, Barash S, Finkbeiner S, Chaijale N, Anderson KE. Hauser RA, et al. Among authors: factor sa. J Clin Psychopharmacol. 2024 Jul-Aug 01;44(4):386-396. doi: 10.1097/JCP.0000000000001885. Epub 2024 Jun 21. J Clin Psychopharmacol. 2024. PMID: 38901008
Correction: Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease.
Frank S, Anderson KE, Fernandez HH, Hauser RA, Claassen DO, Stamler D, Factor SA, Jimenez-Shahed J, Barkay H, Wilhelm A, Alexander JK, Chaijale N, Barash S, Savola JM, Gordon MF, Chen M. Frank S, et al. Among authors: factor sa. Neurol Ther. 2024 Dec;13(6):1747-1749. doi: 10.1007/s40120-024-00660-3. Neurol Ther. 2024. PMID: 39266813 Free PMC article. No abstract available.
Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease.
Frank S, Anderson KE, Fernandez HH, Hauser RA, Claassen DO, Stamler D, Factor SA, Jimenez-Shahed J, Barkay H, Wilhelm A, Alexander JK, Chaijale N, Barash S, Savola JM, Gordon MF, Chen M. Frank S, et al. Among authors: factor sa. Neurol Ther. 2024 Jun;13(3):655-675. doi: 10.1007/s40120-024-00600-1. Epub 2024 Apr 1. Neurol Ther. 2024. PMID: 38557959 Free PMC article.
Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study.
Simuni T, Uribe L, Cho HR, Caspell-Garcia C, Coffey CS, Siderowf A, Trojanowski JQ, Shaw LM, Seibyl J, Singleton A, Toga AW, Galasko D, Foroud T, Tosun D, Poston K, Weintraub D, Mollenhauer B, Tanner CM, Kieburtz K, Chahine LM, Reimer A, Hutten SJ, Bressman S, Marek K; PPMI Investigators. Simuni T, et al. Lancet Neurol. 2020 Jan;19(1):71-80. doi: 10.1016/S1474-4422(19)30319-9. Epub 2019 Oct 31. Lancet Neurol. 2020. PMID: 31678032 Free PMC article.
293 results